Pharmacy Retailing in the Uk | Market Share, Size, Trends, Growth, Analysis and Overview

Submitted by: Submitted by

Views: 10

Words: 957

Pages: 4

Category: Business and Industry

Date Submitted: 05/16/2016 03:31 AM

Report This Essay

Summary

The UK pharmacy market has continued its recovery in 2014, increasing its estimated value by 2.1%, the fastest rate of growth since 2010. This has been driven by the OTC market, which grew nearly 4%, outperforming the larger NHS receipts component. The OTC market has been lifted by improvements in consumer confidence, with people more willing to spend on self-care, health and wellbeing.

Key Findings

- Understand the impact on pharmacy retailing of the Boots/Walgreens merger and how it will increase competitiveness in the sector

- Use the detailed data and insight on the market, including NHS receipts and OTC, to help form an effective growth strategy

- Idenitfy the opportunities to grow business in this sector by comparing strategies of the key players in the market and their performance metrics

- Learn how the UK's ageing population and rising obesity levels will impact the market, allowing you to develop product ranges that are better targeted

Browse Detail Report With TOC @ https://marketreportscenter.com/reports/252407/pharmacy

Synopsis

The longer-term trend toward reclassification of medicines from prescription only to P category and from P to GSL has continued, supporting pharmacy

growth outside the prescription market. As the government seeks to limit NHS budgets and promote self-care, the outperformance of OTC relative to NHS

prescriptions is expected to continue.

The end of the 100-hour control of entry exemption, which had been a significant driver of growth in pharmacy numbers, has begun to have an impact on the market, with far more marginal growth in numbers in 2014. Pharmacy numbers have grown by nearly 20% in 10 years, increasing competition, particularly from smaller operators, including the grocers.

The pressure on NHS budgets is likely to continue over the next five years and this will mean that pharmacy's core prescription medicines business will grow only slowly in value if not in volume. The...